Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group

Summary Objective To report the Italian experience on cinacalcet use following its approval by the European Medical Agency ( EMA ) to control hypercalcaemia in patients with primary hyperparathyroidism ( PHPT ). Design Retrospective data collection from 100 patients with sporadic (s PHPT ) and 35 with familial PHPT (f PHPT ) followed in eight Italian centres between October 2008 and March 2011. Measurements Albumin‐adjusted serum calcium, PTH ,...